Prolonging the honeymoon from hypoglycaemia

Matyka, Krystyna
December 2013
Diabetes Digest;2013, Vol. 12 Issue 4, p192
The article presents studies which examine the risk of severe hypoglycaemia (SH) in the adolescent cohort. A study from Australia shows that there were no associations between glycaemic control and the risk of SH during the observation period of 12 years. Another study recommends that residual beta-cell function (RBF) might offer a supportive role in avoiding SH and facilitating good glycaemic control.


Related Articles

  • Hypoglycaemic events in patients with type 2 diabetes in the United Kingdom: associations with patient-reported outcomes and self-reported HbA1c. Mitchell, Beth D.; Vietri, Jeffrey; Zagar, Anthony; Curtis, Bradley; Reaney, Matthew // BMC Endocrine Disorders;2013, Vol. 13 Issue 1, p59 

    Background: One possible barrier to effective diabetes self-management is hypoglycaemia associated with diabetes medication. The current study was conducted to characterize hypoglycaemic events among UK patients with type 2 diabetes (T2D) treated with antihyperglycaemic medications, and assess...

  • Special considerations for treatment of type 2 diabetes mellitus in the elderly. Fravel, Michelle A.; McDanel, Deanna L.; Ross, Mary B.; Moores, Kevin G.; Starry, Mary J. // American Journal of Health-System Pharmacy;3/15/2011, Vol. 68 Issue 6, p500 

    Purpose. The intensity and selection of therapy for the treatment of type 2 diabetes mellitus in elderly patients are discussed. Summary. Glycemic control is fundamental in diabetes care; however, as glycemic goals are approached, the risk of hypoglycemia increases. This risk is even greater in...

  • Observational Study of Once-Daily Insulin Detemir in People with Type 2 Diabetes Aged 75 Years or Older. Karnieli, Eddy; Baeres, Florian; Dzida, Grzegorz; Ji, Qiuhe; Ligthelm, Robert; Ross, Stuart; Svendsen, Anne; Yale, Jean-François // Drugs & Aging;2013, Vol. 30 Issue 3, p167 

    Objectives: Older patients are particularly vulnerable to hypoglycaemia. The aim of this study was to evaluate the response to initiation of once-daily insulin detemir in patients aged ≥75 years with type 2 diabetes mellitus (T2DM) treated with one or more oral antidiabetic drugs (OADs)....

  • Professional continuous glucose monitoring: Does it improve glycaemic control? Hammond, Peter // Diabetes Digest;2014, Vol. 13 Issue 3, p134 

    The article discusses several studies on new technology for glycaemic control in Type 1 diabetes (T1D). It references published research including one in "Diabetes Technology Therapy" on the use of a professional continuous glucose monitoring (PCGM) device by T1D patients and the use of insulin...

  • Changing the paradigm of type 1 diabetes: It is not a disease of absolute insulin deficiency. Flanagan, Daniel // Diabetes Digest;2014, Vol. 13 Issue 2, p68 

    The article discusses several studies on type 1 diabetes (T1D) published in various journals as of June 2014. Studies presented include one from R. A. Oram and colleagues on the secretion of very-low-level endogenous insulin among people with long-duration T1D, another from D. M. Maahs and...

  • Associations of A-FABP with Anthropometric and Metabolic Indices and Inflammatory Cytokines in Obese Patients with Newly Diagnosed Type 2 Diabetes. Niu, Guifen; Li, Jian; Wang, Huaiguo; Ren, Yuan; Bai, Jie // BioMed Research International;10/13/2016, Vol. 2016, p1 

    The study aimed to evaluate the relationship between anthropometric and metabolic indices, inflammatory cytokines, and adipocyte fatty acid-binding protein (A-FABP) in obese patients with newly diagnosed type 2 diabetes. The study included 48 nonobese subjects with newly diagnosed type 2...

  • Updated Review: Improved Glycemic Control with Repaglinide-Metformin in Fixed Combination for Patients with Type 2 Diabetes. Richard III, John W.; Raskin, Philip // Clinical Medicine Insights: Endocrinology & Diabetes;2011, Issue 4, p29 

    As the prevalence of type 2 diabetes continues to rise, new drug therapies will need to be explored to prevent morbidity and mortality associated with diabetes as well as growing health care costs. Type 2 diabetes is characterized by decreased insulin secretion and sensitivity. Numerous oral...

  • Evaluation of an insulin pump service. Swinhoe, Kim // Journal of Diabetes Nursing;2012, Vol. 16 Issue 4, p140 

    Continuous subcutaneous insulin infusion (CSII) is recommended as a treatment option for adults or children with type 1 diabetes. Several studies have indicated that intensive diabetes management with CSII improves glycaemic control while reducing severe hypoglycaemia. In this service...

  • Hypoglycaemia. Sen Gupta, Piya; Green, Andrea N.; Chowdhury, Tahseen A. // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;2/19/2011, Vol. 342 Issue 7794, p438 

    The article discusses the medical case of a 58-year-old white man who has had type 2 diabetes for almost a decade. The patient experiences frequent hypoglycaemic episodes and regularly takes a daily dose of basal insulin glargine. The article explains that hypoglycaemia in diabetic patients...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics